Infants and children aged <2 years are strongly recommended to receive MenB vaccine
All infants and children aged <2 years are strongly recommended to receive MenB vaccine. Bexsero is the only MenB vaccine that can be used in infants and children aged <10 years.
The number of doses required depends on the age of the child when they start the vaccine course.
Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.
|
Age at start of vaccine course |
MenB vaccine brand |
Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease) |
|
6 weeks to 5 months |
Bexsero |
3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
|
6–11 months |
Bexsero |
3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
|
12–23 months |
Bexsero |
2 doses (8 weeks between doses) |
Page history
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/infants-and-children-aged-4.